We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0AAU market cap is 0. The company's latest EPS is SEK and P/E is N/A.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 101.52M | 104.8M | 366.78M | 802.54M | 882.85M |
| Operating Income | 15.18M | 19.97M | 56.52M | 162.54M | 189.15M |
| Net Income | 12.6M | 15.61M | 86.25M | 187.97M | 233.97M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 456.21M | 472.27M | 3.98B | 4.65B | 4.7B |
| Total Liabilities | 54.54M | 45.22M | 393.06M | 413.11M | 357.46M |
| Total Equity | 401.68M | 427.05M | 3.59B | 4.24B | 4.35B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | 55.2M | 23.23M | 39.08M | 129.49M | 238.29M |
| Investing | -210.3M | -8.69M | -2.73B | -34.55M | -44.13M |
| Financing | 185.78M | 4.21M | 2.92B | 17.09M | 15.85M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 51.03M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Surgical Science Sweden Ab |
| Address |
drakegatan 7 a, 3 tr goteborg 412 50 |
| Website | https://www.surgicalscience.com |
| Industry | schools & education svcs,nec (8299) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
